ERBB2 and breast cancer: Triple-negative breast cancer (TNBC), an aggressive breast cancer subtype, lacks the expression of the progesterone receptor, human epidermal growth factor receptor 2 (HER2), and estrogen receptor (Shang & Xu, 2022).